Serum AKR1B10 as an indicator of unfavorable survival of hepatocellular carcinoma. Xie C, Ye X, Zeng L, Zeng X, et al. J Gastroenterol 2023 Jul 27. doi: 10.1007/s00535-023-02011.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xie C, Ye X, Zeng L, Zeng X, et al. Serum AKR1B10 as an indicator of unfavorable survival of hepatocellular carcinoma. J Gastroenterol 2023 Jul 27. doi: 10.1007/s00535-023-02011.
PMID: 37500927